Timothy R Franson - Net Worth and Insider Trading
Timothy R Franson Net Worth
The estimated net worth of Timothy R Franson is at least $167,507 dollars as of 2024-04-27. Timothy R Franson is the Director of Paratek Pharmaceuticals Inc and owns about 72,000 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $160,560. Timothy R Franson is also the Director of Cidara Therapeutics Inc and owns about 550 shares of Cidara Therapeutics Inc (CDTX) stock worth over $6,947. Details can be seen in Timothy R Franson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Timothy R Franson has not made any transactions after 2023-02-21 and currently still holds the listed stock(s).
Transaction Summary of Timothy R Franson
Timothy R Franson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy R Franson owns 3 companies in total, including Cidara Therapeutics Inc (CDTX) , Paratek Pharmaceuticals Inc (PRTK) , and Myrexis Inc (MYRX) .
Click here to see the complete history of Timothy R Franson’s form 4 insider trades.
Insider Ownership Summary of Timothy R Franson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | 2021-09-13 | director |
| PRTK | Paratek Pharmaceuticals Inc | 2023-09-21 | director |
| MYRX | Myrexis Inc | 2011-12-08 | director |
Timothy R Franson Latest Holdings Summary
Timothy R Franson currently owns a total of 2 stocks. Among these stocks, Timothy R Franson owns 72,000 shares of Paratek Pharmaceuticals Inc (PRTK) as of February 21, 2023, with a value of $160,560 and a weighting of 95.85%. Timothy R Franson also owns 550 shares of Cidara Therapeutics Inc (CDTX) as of September 13, 2021, with a value of $6,947 and a weighting of 4.15%.
Latest Holdings of Timothy R Franson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRTK | Paratek Pharmaceuticals Inc | 2023-02-21 | 72,000 | 2.23 | 160,560 |
| CDTX | Cidara Therapeutics Inc | 2021-09-13 | 550 | 12.63 | 6,947 |
Holding Weightings of Timothy R Franson
Timothy R Franson Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy R Franson has made a total of 1 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Paratek Pharmaceuticals Inc is the sale of 7,000 shares on February 21, 2023, which brought Timothy R Franson around $13,160.
According to the SEC Form 4 filings, Timothy R Franson has made a total of 1 transactions in Cidara Therapeutics Inc (CDTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cidara Therapeutics Inc is the acquisition of 350 shares on September 13, 2021, which cost Timothy R Franson around $14,840.
Insider Trading History of Timothy R Franson
- 1
Timothy R Franson Trading Performance
GuruFocus tracks the stock performance after each of Timothy R Franson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy R Franson is -12.52%. GuruFocus also compares Timothy R Franson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy R Franson within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy R Franson's insider trading performs compared to the benchmark.
Performance of Timothy R Franson
Average Return
-37%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.94 | -12.52 | -34.24 | -37 | -31.46 | -36.55 |
| Relative Return to S&P 500(%) | -2.37 | -15.43 | -29.62 | -31.04 | -34.4 | -44.87 |
Timothy R Franson Ownership Network
Ownership Network List of Timothy R Franson
Ownership Network Relation of Timothy R Franson
Timothy R Franson Owned Company Details
What does Cidara Therapeutics Inc do?
Who are the key executives at Cidara Therapeutics Inc?
Timothy R Franson is the director of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , Chief Medical Officer Taylor Sandison , and CFO & CBO Preetam Shah .
Cidara Therapeutics Inc (CDTX) Insider Trades Summary
Over the past 18 months, Timothy R Franson made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 48,874 shares made by Leslie Tari , a net sale of 46,658 shares made by Taylor Sandison , and a net purchase of 100,000 shares made by Jeffrey Stein .
In summary, during the past 3 months, insiders sold 4,055 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 4,055 shares. During the past 18 months, 7,796 shares of Cidara Therapeutics Inc (CDTX) were sold and 5,500 shares were bought by its insiders, resulting in a net sale of 2,296 shares.
Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cidara Therapeutics Inc Insider Transactions
Timothy R Franson Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy R Franson. You might contact Timothy R Franson via mailing address: 320 Wakara Way, Salt Lake City Ut 84108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
